Mutations in are prevalent in various myeloid and lymphoid malignancies. The most common R882 mutations inhibit methyltransferase activity of the remaining wild-type DNMT3A proteins at a heterozygous state due to their dominant-negative activity. Reports and COSMIC database analysis reveal significantly different frequencies of R882 mutations in myeloid versus T-cell malignancies, inspiring us to investigate whether downregulation of regulates malignancies of different lineages in a dose-dependent manner.
View Article and Find Full Text PDFCamptothecin (CPT) has been used for colorectal cancer therapy. At low concentration of 10M, CPT modulates endothelial nitric oxide production following the phosphorylation of LKB1 Ser431, AMPK-α Thr172, eNOS Ser633 and Ser1177. Elevated nitric oxide (NO) was observed by FA-OMe fluorescent probe.
View Article and Find Full Text PDF